XLP

4 registered clinical trials studyying XLP — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoi NCT05005975	Tanabe Pharma America, Inc.	Phase 3
Completed	Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria NCT04402489	Tanabe Pharma America, Inc.	Phase 3
Completed	Oral Iron for Erythropoietic Protoporphyrias NCT02979249	Icahn School of Medicine at Mount Sinai	N/A
Completed	Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosoc NCT01688895	Icahn School of Medicine at Mount Sinai	—